Natal status of infants of cocaine users and control subjects: a prospective comparison
- PMID: 8558338
Natal status of infants of cocaine users and control subjects: a prospective comparison
Abstract
Cocaine use by pregnant women has increased dramatically in recent years. To assess the effect of maternal cocaine use on infant outcome, we enrolled 224 women (105 cocaine users, 119 control subjects) and their infants (all of 34 weeks or more gestational age and nonasphyxiated) in a prospective, blinded study. Results showed that infants exposed to cocaine were more likely to be admitted to the newborn intensive care unit, be treated for congenital syphilis, have a greater length of stay, and be discharged to a person other than the mother (all p < 0.01). Birth weight and head circumference, adjusted for gestational age, were smaller in the infants exposed to cocaine than in control infants (p < 0.001). After statistically controlling for cigarette use and other confounders, however, the odds of infants exposed to cocaine and control infants having birth weight and head circumferences less than the 25th percentile for gestational age did not differ (both p > 0.80). Infants of cocaine-using mothers and control subjects had a similar incidence of abnormal cranial and renal ultrasonographic findings and abnormal pneumocardiograms (all p > or = 0.32). We conclude that in this cohort of nonasphyxiated infants of 34 weeks or more gestational age, infants exposed to cocaine had more medical and social problems than control infants but did not differ statistically in the incidence of severe growth retardation, abnormal cranial or renal ultrasonographic findings, or abnormal pneumocardiograms. We suggest that natal interventions for the nonasphyxiated term and near-term infant exposed to cocaine should include a careful history and physical examination, follow-up plans, and social service involvement.
Similar articles
-
Cocaine/polydrug use in pregnancy: two-year follow-up.Pediatrics. 1992 Feb;89(2):284-9. Pediatrics. 1992. PMID: 1370867
-
Health-care utilization among mothers and infants following cocaine exposure.J Perinatol. 2003 Jul-Aug;23(5):361-7. doi: 10.1038/sj.jp.7210946. J Perinatol. 2003. PMID: 12847529
-
Brain growth among fetuses exposed to cocaine in utero: asymmetrical growth retardation.Obstet Gynecol. 1991 Mar;77(3):361-4. Obstet Gynecol. 1991. PMID: 1992399
-
Risks associated with cocaine use during pregnancy.Obstet Gynecol. 1992 May;79(5 ( Pt 1)):778-89. Obstet Gynecol. 1992. PMID: 1565365 Review.
-
Cocaine abuse and reproduction.Int J Clin Pharmacol Ther. 1994 Jan;32(1):7-11. Int J Clin Pharmacol Ther. 1994. PMID: 8199753 Review.
Cited by
-
Potential latent effects of prenatal cocaine exposure on growth and the risk of cardiovascular and metabolic disease in childhood.Prog Pediatr Cardiol. 2011 Jan 1;31(1):59-65. doi: 10.1016/j.ppedcard.2010.11.010. Prog Pediatr Cardiol. 2011. PMID: 21318092 Free PMC article.
-
Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Problems of dose and confounding.Ann N Y Acad Sci. 1998 Jun 21;846:40-50. Ann N Y Acad Sci. 1998. PMID: 9668396 Free PMC article. Review.
-
Level of in utero cocaine exposure and neonatal ultrasound findings.Pediatrics. 1999 Nov;104(5 Pt 1):1101-5. doi: 10.1542/peds.104.5.1101. Pediatrics. 1999. PMID: 10545554 Free PMC article.
-
Effect of socioeconomic status disparity on child language and neural outcome: how early is early?Pediatr Res. 2016 Jan;79(1-2):148-58. doi: 10.1038/pr.2015.202. Epub 2015 Oct 20. Pediatr Res. 2016. PMID: 26484621 Review.
-
Fifty Years of Research on Prenatal Substances: Lessons Learned for the Opioid Epidemic.Advers Resil Sci. 2020 Dec;1(4):223-234. doi: 10.1007/s42844-020-00021-7. Epub 2020 Oct 27. Advers Resil Sci. 2020. PMID: 34316723 Free PMC article.